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Type I interferon is required for T helper (Th) 2
induction by dendritic cells
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Abstract
Type 2 inflammation is a defining feature of infection with para-
sitic worms (helminths), as well as being responsible for wide-
spread suffering in allergies. However, the precise mechanisms
involved in T helper (Th) 2 polarization by dendritic cells (DCs) are
currently unclear. We have identified a previously unrecognized
role for type I IFN (IFN-I) in enabling this process. An IFN-I signa-
ture was evident in DCs responding to the helminth Schistosoma
mansoni or the allergen house dust mite (HDM). Further, IFN-I
signaling was required for optimal DC phenotypic activation in
response to helminth antigen (Ag), and efficient migration to, and
localization with, T cells in the draining lymph node (dLN). Impor-
tantly, DCs generated from Ifnar1/ mice were incapable of initi-
ating Th2 responses in vivo. These data demonstrate for the first
time that the influence of IFN-I is not limited to antiviral or bacte-
rial settings but also has a central role to play in DC initiation of
Th2 responses.
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Introduction
Although both helminth infection and allergies exert a devastating
global impact and lack effective vaccines or refined therapeutics,
basic understanding of the key cell types and mediators that initiate
and control type 2 immunity is limited. Despite the potential for
innate immune cells such as group 2 innate lymphoid cells to influ-
ence type 2 responses (McKenzie et al, 2014), it is DCs that are criti-
cal for activation and polarization of Th2 immunity (Hammad et al,
2010; Phythian-Adams et al, 2010; McKenzie et al, 2014). However,
the signals that DCs provide to facilitate Th2 polarization remain
unclear (MacDonald & Maizels, 2008; Bouchery et al, 2014).
IFN-I is most well known for its pro-inflammatory role in antivi-
ral immunity (Hoffmann et al, 2015). However, this large family of
cytokines (including 14 IFNa subtypes in mice, as well as IFNb)
exert diverse effects in a range of infection settings (Bouchery et al,
2014; McNab et al, 2015). All IFN-I subtypes bind to a common
receptor expressed on immune, stromal, and epithelial cells, and
studies using IFN-I receptor-deficient mice (Ifnar1/) indicate that
IFN-I signaling can either enhance or impair the inflammatory
response during viral and bacterial infection, depending on context
(Ivashkiv & Donlin, 2014; McNab et al, 2015). Many IFN-I effects
are mediated by a direct impact on DC phenotype and functionality.
For example, IFN-I responsiveness controls the ability of CD8a+
cDC1s to cross-present viral and tumor Ag to CD8+ T cells
(Diamond et al, 2011; Pinto et al, 2011; Ivashkiv & Donlin, 2014) and
also influences DC activation, migration, and T cell priming in vitro
(Parlato et al, 2001; Montoya, 2002; Mattei et al, 2009; Diamond
et al, 2011; Pinto et al, 2011). Although it has been suggested that
IFN-I may be produced by DCs exposed to live Schistosoma mansoni
eggs (Trottein et al, 2004), the role of IFN-I in type 2 inflammation,
and how DC function may be modulated by this cytokine family
during the orchestration of Th2 responses, is unknown.
We have investigated the key factors involved in DC activation
and function during Th2 induction using in vitro-generated murine
Flt3-L BMDCs (FLDCs), which reflect the heterogeneity and
complexity of DC subsets in vivo (Naik et al, 2005), and using
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in vivo models of Th2 priming. These studies indicate that in
addition to producing IFN-I in response to helminth Ag and aller-
gens, DC-intrinsic IFN-I signaling is required for their effective
migration, localization, and Th2 induction in vivo. For the first time,
we establish a central role for IFN-I as an early positive regulator of
Th2 immunity and demonstrate that IFN-I signaling is essential for
optimal DC function during type 2 priming.
Results
An IFN-I signature and Th2 induction by FLDCs
To date, studies have failed to identify a defined DC phenotypic acti-
vation profile in response to Th2-polarizing helminths (MacDonald
& Maizels, 2008; Bouchery et al, 2014). Previous work in this area
has predominantly been carried out using murine GM-CSF-derived
BMDCs (GMDCs) or cell lines (MacDonald et al, 2001; Trottein
et al, 2004). However, FLDCs better represent DC subsets in vivo
(Naik et al, 2005; Helft et al, 2015), generating CD24hi equivalents
of CD8a+ cDC1s, CD11b+ cDC2s, and plasmacytoid DCs (pDCs;
Fig 1A; Brasel et al, 2000; Gilliet et al, 2002; Guilliams et al, 2014).
FLDCs were cultured overnight with the potent Th2-inducing
soluble egg Ag from S. mansoni (SEA; MacDonald & Maizels, 2008),
or heat-killed Salmonella typhimurium (St) as a Th1/17 control
(Perona-Wright et al, 2012; Cook et al, 2015). Surprisingly, FLDCs
secreted significant levels of IFN-I in response to SEA, including
IFNa3 and IFNb, in excess of that induced by St (Fig 1B). IFN-I
production by FLDCs responding to Th2-Ag was not restricted to
SEA, but was also evident following their exposure to the allergen
house dust mite (HDM; Fig 1C). Despite significant IFN-I induction,
SEA failed to stimulate production of the inflammatory mediators
IL-1b, IL-6, IL-12p40, IL-12p70, or TNFa, or regulatory IL-10, from
FLDCs (Fig 1D), as reported previously by our group and others
using GMDCs or human PBMC DCs (MacDonald et al, 2001; de Jong
et al, 2002). In stark contrast, St induced high-level production of
these cytokines (Fig 1D). Although it has recently been suggested
that DC-derived IL-10 and IL-33 are important inducers of Th2
responses (Williams et al, 2013), we were unable to detect signifi-
cant levels of either IL-10 (Fig 1D) or IL-33 (Fig EV1A) following
FLDC exposure to SEA.
In order to assess whether IFN-I induction by the soluble extract
SEA was also evident with whole S. mansoni eggs, we cultured
FLDCs with live or dead eggs (Fig 1E). This demonstrated signifi-
cant induction of both IFNa3 and IFNb following FLDC exposure to
dead eggs, as well as a clear IFN-I signature in the form of upregu-
lated IFN-stimulated genes (ISGs), including Ifit1, Mx1, and Oas1a
(Fig EV1B). Co-culture of FLDCs with live eggs showed only a trend
toward IFN-I secretion and ISG induction, suggesting that the
components responsible for DC IFN-I production are predominantly
released from dead, or dying, eggs. In addition, IFN-I production
was also detected in FLDCs exposed to the T2 ribonuclease (RNase)
omega-1 (Everts et al, 2009; Wilbers et al, 2017), which is the major
Th2 immunostimulatory factor in, and one of the most abundant
components of, S. mansoni egg secretions (Cass et al, 2007; Fig 1F).
To identify which FLDC subset(s) produced IFN-I in response to
Th2-inducing Ag, cells were sorted prior to SEA stimulation, demon-
strating that the primary source was cDC1s (Fig 1G). This was
unexpected, given that pDCs are a key source of this cytokine,
particularly in early viral infection (Swiecki & Colonna, 2010). As a
complementary approach, we cultured FLDCs generated from mice
that express GFP when IFNa6 is expressed (Kumagai et al, 2007)
with SEA, CpG, or HDM (Fig 1H). These IFNa6 reporter cells con-
firmed that in addition to cDC1-restricted production of IFNa3
(Fig 1G), both cDC1s and cDC2s had the capacity to produce IFNa6
in response to SEA. They also demonstrated that pDCs did not
respond to the Th2-associated Ags SEA or HDM with upregulation
of IFN-I production and that, although HDM promoted FLDC IFNa3
and IFNb (Fig 1C), no IFNa6 was induced in either cDCs or pDCs by
this allergen. As expected, CpG was the most effective IFNa6 stimu-
lus in all three FLDC subsets. Together, this shows that cDCs, and
particularly cDC1s, can produce IFN-I in response to both helminth
Ag and allergens, as has been reported for antiviral settings (Diebold
et al, 2003; Kato et al, 2005).
cDC1s in vivo produce IFN-I in response to TLR3-TRIF agonists
such as polyI:C (Miyake et al, 2009), while pDCs primarily produce
IFN-I following TLR7 or TLR9 stimulation in a MyD88-dependent
manner (McNab et al, 2015). In agreement with this, we found that
FLDC production of IFN-I in response to SEA was TRIF-dependent,
not MyD88-dependent (Fig 1I). In fact, IFN-I induction was nega-
tively regulated by MyD88 (Fig 1I), a phenomenon reported for
TRIF-dependent cytokine responses in macrophages (Johnson et al,
2008), but not previously identified as a mechanism of regulating
TRIF-dependent IFN-I production in DCs.
In addition to their impact on DC cytokine secretion, SEA and St
upregulated expression of surface molecules associated with Ag
presentation and costimulation (MHC II, CD40, and CD86) in both
cDC1s and cDC2s (Fig EV1C and E), while pDC phenotypic activa-
tion was not dramatically altered by either Ag (Fig EV1C). It has
recently been suggested that expression of PD-L2 and CD301b may
be typical of DCs activated with Th2-inducing Ag (Gao et al, 2013;
Kumamoto et al, 2013). Although upregulation of PD-L2 was
observed on cDCs responding to SEA, increased expression of this
marker was not restricted to Th2 Ag, but was also evident on DCs
responding to St (Fig EV1D and F). Neither Ag influenced the low
level of CD301b expressed by any FLDC subset (Fig EV1G). Notably,
in most cases, the degree to which activation molecules were upreg-
ulated was less striking with SEA than St (Fig EV1). This muted
cDC surface activation following exposure to SEA is in keeping with
previous reports of GMDCs or human PBMC DCs exposed to SEA
in vitro, or splenic and hepatic DCs from S. mansoni-infected mice,
and may reflect an alternative, and more restricted, DC activation
phenotype that is common to Th2 settings (MacDonald et al, 2001;
de Jong et al, 2002; Straw et al, 2003; MacDonald & Maizels, 2008;
Lundie et al, 2016).
In order to act as effective Ag-presenting cells (APCs), DCs must
be able to migrate to the dLN (Alvarez et al, 2008). Since the role of
the different DC subsets in Th2 priming is currently unclear
(MacDonald & Maizels, 2008; Bouchery et al, 2014), and FLDC abil-
ity to generate Th2 responses has not yet been addressed, we next
assessed their capacity to migrate effectively, and to initiate and
polarize immune responses after adoptive transfer into naı̈ve mice.
Following injection of dsRed+ FLDCs, cDCs capably trafficked to
the dLN (Fig 2A and B). Transferred CD45R+ pDCs could not be
detected in the dLN (Fig 2A), in agreement with previous work
demonstrating that pDCs can only gain entry to a LN via the blood
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through inflamed high endothelial venules and do not routinely
migrate via the lymphatics (Diacovo, 2005). While the proportions
of cDC1s and cDC2s were approximately 50:50 in cultures prior to
transfer (as in Fig 1A), the majority of DCs reaching the dLN were
cDC2s (Fig 2A and C), consistent with the suggestion that cDC2s are
the primary DC subset that polarizes Th2 responses in vivo
(Tussiwand et al, 2015). Interestingly, even though SEA-exposed
cDCs maintained a muted activation phenotype post-transfer
(Fig 2D), a characteristic that has also been identified in vivo during
S. mansoni infection (Straw et al, 2003), they competently migrated
to the dLN T cell zones (Fig 2E). In addition, despite their limited
activation profile, and significant IFN-I production, SEA-exposed
FLDCs effectively promoted Th2 polarization following transfer,
with clear induction of IL-4, IL-5, IL-10, and IL-13 in dLN restimula-
tions (Fig 2F). As in many Th2 settings (Pearce & MacDonald,
2002), transferred FLDCs also induced SEA-specific IFNc. It is possi-
ble that the minor population of cDC1s present in the dLN were






Figure 1. FLDCs produce IFN-I in response to Th2 Ag.
A FLDC subsets were defined by expression of CD11c, CD45R (B220), CD11b, and CD24. pDCs were identified as CD45R+ CD11clo; cDCs are CD11c+ CD45R with cDC1
and cDC2 subsets.
B, C IFN-I production as measured by ELISA on supernatants from bulk cultures cultured in medium alone (M) or stimulated with 25 lg/ml soluble egg Ag from
Schistosoma mansoni (SEA) (B, C), 5 lg/ml Salmonella typhimurium (St) (B), or 50 lg/ml house dust mite (HDM) extract (C).
D Production of DC cytokines from bulk cultures following exposure to SEA or St.
E–G IFN-I production as measured by ELISA on supernatants from bulk cultures cultured in medium alone (M) or stimulated with 1:500 live or dead whole S. mansoni
eggs (E), 0.5 lg/ml recombinant omega-1 (F), or FACS-isolated subsets after stimulation with SEA (G).
H Percentage of IFNa6GFP+ DCs after stimulation with SEA, 1 lg/ml CpG, or HDM.
I IFNa3 production by WT, Myd88/, and Trif/ bulk FLDCs after exposure to SEA.
Data information: Results are mean  SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one-way ANOVA). Data from one of three or more experiments (n = 3
replicate wells per group).
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setting, as has been reported with the in vivo equivalents of this
subtype (Everts et al, 2016). In keeping with their inflammatory
phenotype, St-exposed FLDCs capably induced recipient IL-10,
IL-17, and IFNc production (Fig 2G). Consistent with previous
reports, no IL-17 was detectable following SEA-activated DC transfer
(Larkin et al, 2012; Cook et al, 2015) and no Th2 cytokines were
evident following St-activated DC transfer.
FLDCs depend on IFN-I signaling for Th2 induction
Having established that SEA triggered FLDC IFN-I secretion (Fig 1),
while also conferring Th2-initiation ability (Fig 2), we next
addressed the importance of IFN-I production in the Th2 induction
process. Given that DCs themselves can be a target of IFN-I (Mon-
toya, 2002; Mattei et al, 2009), we first determined whether IFN-I-
responsiveness was required for optimal DC function following SEA
stimulation. To this end, we used Ifnar1/ mice to generate FLDCs
lacking the IFNAR1 subunit of the IFN-I receptor, thus rendering
them unresponsive to IFN-I (Hwang et al, 1995). Ifnar1/ FLDCs
displayed significantly reduced expression of the ISGs Ifit1 and Mx1
in response to SEA (Fig 3A), and markedly impaired secretion of
IFN-I (Fig 3B), consistent with previous reports using Ifnar1/
fibroblasts in non-Th2 settings (Marié et al, 1998). Additional
aspects of SEA-induced activation of WT cDC1s and cDC2s were
dramatically impaired in Ifnar1/ FLDCs, with reduced expression





Figure 2. FLDCs migrate to the dLN and induce Ag-specific responses following adoptive transfer.
Following Ag stimulation, dsRed+ FLDCs were injected s.c. into naïve WT mice, and 48 h later, dLNs were harvested and the presence of dsRed+ CD11c+ cells was assessed by
flow cytometry (A, B) or confocal microscopy (E).
A dsRed+ CD11c+ FLDCs were gated as pDCs (CD45R+), cDC1s (CD45R CD24+), or cDC2s (CD45R CD11b+).
B Absolute numbers of dsRed+ CD11c+ FLDCs in the dLN calculated from flow analysis and cell counts.
C Percentage of transferred dsRed+ CD11c+ cells that were cDC1s or cDC2s.
D CD86 expression on transferred dsRed+ CD11c+ FLDCs.
E Confocal microscopy of dLN sections after FLDC transfer: Upper row depicts overlay of CD3 (green), CD45R (gray) and dsRed (red); bottom row depicts dsRed (red)
alone. White dashed line represents division between T cell (CD3+) and B cell zones (CD45R+). Scale bars represent 38 lm.
F, G Seven days after transfer, dLN cells were restimulated for 72 h with 15 lg/ml SEA (F), 1 lg/ml St (G), or medium alone (M) and cytokine production assessed by ELISA.
Data information: Results are least squares mean  SEM (B–D) or mean  SEM (F, G). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (analyzed using a three-way
full-factorial fit model, with contrast analysis used to test differences between experimental groups (B–D) or one-way ANOVA (F, G)). Data from one of three or more
experiments (A, E–G) or three experiments pooled (B–D) (n = 3–9 animals per group). gMFI, geometric mean fluorescence intensity.
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implicated in controlling many aspects of DC function, not limited
to surface activation and cytokine production, but also regulating
their survival and turnover (Mattei et al, 2009). However, we did
not identify any defect in either differentiation, or survival, of
Ifnar1/ FL-cDCs (Fig EV2). Most strikingly, in the absence of
IFNAR1, the ability of FLDCs to promote SEA-specific Th2 responses
in vivo was completely ablated, while IFNc induction by these DCs
was not significantly affected (Fig 3D). Further, using IL-4 reporter
mice (Mohrs et al, 2005) as recipients, we found that Ifnar1/
SEA-activated FLDCs displayed impaired ability to prime CD4+ T
cell IL-4 secretion (huCD2) or mRNA expression (eGFP) in vivo





Figure 3. FLDCs depend on IFN-I signaling for optimal activation and Th2 induction.
A–D WT or Ifnar1/ FLDCs were cultured with 25 lg/ml SEA or in medium alone (M) for 6 h for gene expression analysis (A) (normalized against Gapdh, a.u.) or 18 h
for analysis of IFN-I production (B), surface phenotype (C), or injection s.c. into naïve WT mice (D). (D) Seven days after transfer, dLN cells were restimulated for
72 h with 15 lg/ml SEA or medium alone and cytokine production assessed by ELISA (medium-stimulation-alone values subtracted).
E WT or Ifnar1/ FLDCs were transferred s.c. into KN2xIL-4eGFP mice; 7 days later, the presence of IL-4+ (huCD2+, IL-4 protein) and IL-4eGFP+ (IL-4 mRNA) CD4+ T
cells was assessed by flow cytometry.
Data information: Results are mean  SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one-way ANOVA). Data from one of three or more experiments (n = 3
replicate wells (A–C) or 5 animals (D, E) per group). a.u., arbitrary units. gMFI, geometric mean fluorescence intensity.
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responsiveness is essential for optimal DC activation by Th2-indu-
cing Ag and is a key factor governing DC Th2 priming ability
in vivo.
cDCs depend on IFN-I signaling for effective migration to, and
localization within, the dLN
To determine why Ifnar1/ FLDCs were impaired in their Th2
induction ability, we first assessed their capacity to process and
present Ag to OVA-specific OT-II CD4+ T cells. T cell proliferation
was comparable in co-cultures containing WT or Ifnar1/ cDCs
with either OVA protein (OVA) or peptide (pOVA) indicating that
Ifnar1/ cDCs had no defect in their capacity to capture, process,
or present Ag in vitro (Fig 4A and B). Supporting unimpaired Ag
uptake and processing in the absence of IFNAR responsiveness,
Ifnar1/ cDCs internalized and processed DQ-OVA as effectively as
WT (Fig 4C). Further demonstrating that Ifnar1/ cDCs displayed
no fundamental deficiency in their ability to polarize CD4+ T cells
in vitro, both WT and Ifnar1/ cDCs co-cultured with IL-4, IL-13,
or IL-10 reporter CD4+ T cells (Mohrs et al, 2005; Kamanaka et al,
2006; Neill et al, 2010; Cook et al, 2015) effectively induced T cell
expression of huCD2 (IL-4; Fig 4D), IL-10eGFP (Fig 4E), and IL-
13eGFP (Fig 4F) under polarizing conditions. These in vitro experi-
ments indicate that DC Ag uptake, processing, and presentation
were not significantly impaired in the absence of IFNAR1 signaling.
The ability of Ifnar1/ cDCs to activate and polarize Th2 cells
in vitro (Fig 4), but not in vivo (Fig 3), strongly suggested that IFN-I
responsiveness may be important for effective migration of Th2-
promoting DCs. As DC migration through the lymphatic system, and
within the dLN, is governed by the chemokine receptor CCR7 and
its ligands CCL21 and CCL19 (Braun et al, 2011), we next assessed
FL-cDC subset expression of CCR7 (Fig 5A). Both cDC subsets
expressed low levels of CCR7 on their surface in medium-alone
conditions, which may account for the steady-state migration that
was evident following adoptive transfer of these unstimulated cells
(Fig 2B). cDC1s and cDC2s upregulated CCR7 following SEA expo-
sure, and this was significantly reduced in the absence of IFNAR1
(Fig 5A). However, we saw little expression of CXCR5 on WT or
Ifnar1/ cDCs (Fig 5B), despite effective staining of this chemokine




Figure 4. Ifnar1/ FL-cDC APC function is comparable to WT FL-cDC in vitro.
A, B FL-cDCs were sorted and co-cultured with CFSE-labeled OT-II T cells, with either OVA protein (OVA) or peptide (pOVA), for 96 h. Proliferation was determined by
flow cytometric analysis of CFSE dilution. The gray dashed line represents non-proliferating OT-II T cell controls.
C To assess Ag uptake and processing, WT or Ifnar1/ FLDCs were cultured with DQ-OVA for 2 h at 37°C or 4°C and uptake assessed by flow cytometry.
D–F Sorted FL-cDCs were cultured with eGFP CD4+ T cells from KN2xIL-13eGFP or KN2xIL-10eGFP animals, with anti-CD3, in the presence (+) or absence () of
20 ng/ml rIL-4. IL-4 (huCD2, D), IL-10eGFP (E), or IL-13eGFP (F) expression on CD4+ T cells was assessed by flow cytometry after 72 h of culture. Positive cells were
expressed as a percentage of all CD4+ T cells.
Data information: Results are mean  SEM. **P < 0.01, ***P < 0.001, ****P < 0.0001 (one-way ANOVA). Data from one of three experiments (n = 4–5 wells per group).
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(Fig EV3A) and T follicular helper cells (Fig EV3B), and in contrast
to previous work suggesting that CXCR5 is required for DC induc-
tion of Th2 responses (León et al, 2012).
Our tracking experiments using WT dsRed+ FLDCs had demon-
strated efficient migration of cDCs to dLN T cell zones following
adoptive transfer (Fig 2A–C). However, in the absence of IFNAR1
expression, cDC numbers reaching the dLN after injection were
reduced by ~50% (Fig 5C). Since CCR7 is required for effective
migration of cDCs to, and appropriate localization within, dLN
(Braun et al, 2011), confocal microscopy was used to determine the
location of transferred Ifnar1/ DCs (Fig 5D). While the majority
of WT SEA-exposed dsRed+ FLDCs homed to the dLN T cell zones,
there was a significant reduction in the proportion of Ifnar1/ SEA-
exposed DCs found within this region (Fig 5D). In agreement with
our phenotypic studies prior to transfer (Figs 3C and 5A), Ifnar1/
SEA-exposed cDCs expressed lower levels of CD86 and CCR7 on
their surface post-transfer, compared to WT (Fig 5E). Similarly,
LFA-1 expression was lower on Ifnar1/ DCs compared to WT
post-transfer, while ICAM-1 levels were equivalent (Fig 5E).
IFN-I involvement in Th2 development in vivo is not restricted
to FLDCs
Having identified that IFNAR1 plays a key role in regulating activa-
tion of FLDCs responding to Th2 Ag in vitro (Fig 1), and their ability
to initiate Th2 responses in vivo (Fig 3), we next assessed the
broader role of this signaling pathway in Th2 priming in vivo.
We first investigated the expression of ISGs in splenic cDCs
purified by FACS from mice challenged intravenously (i.v.) with
SEA (Fig 6A). This demonstrated significant upregulation of a
range of ISGs by cDCs responding to SEA in vivo, including Ifit1,
Ifit3, and Mx1 (Fig 6B). ISG upregulation was not restricted to
the spleen, as mice that had been sensitized intraperitoneally
(i.p.) and challenged i.v. with dead S. mansoni eggs (Wynn et al,
1997) showed significant expression of the ISGs Mx1 and Oasl2r
in the lung (Fig 6C). Further, when mice were sensitized intrader-
mally (i.d.) with HDM, cDC expression of the IFN-responsive
surface markers CD317 (Blasius et al, 2006) and Sca-1 (Essers




Figure 5. FL-cDC migration and localization in vivo is deficient in the absence of IFNAR signaling.
A, B WT or Ifnar1/ FLDCs were cultured for 18 h with 25 lg/ml SEA, or in medium alone (M) and CCR7 (A) and CXCR5 (B) expression assessed by flow cytometry.
C–E WT or Ifnar1/ dsRed+ FLDCs were injected s.c. into WT mice, and dLNs were harvested 48 h later and analyzed by flow cytometry (C) or confocal microscopy (D)
to identify dsRed+ cells. (C) The total number of dsRed+ cDCs in the dLN was calculated from flow data and cell counts. WT data are from the same pooled
experiments as Fig 2B. (D) Left image shows an overlay of CD45R+ B cells (gray) and dsRed+ cells (red). Scale bar represents 1 mm. Right image shows dsRed alone
(gray), white dashed line represents B cell zone of LN, defined by CD45R staining in left image. Images shown are of dLN following transfer of WT FLDCs cultured in
medium alone. The percentage of WT and Ifnar1/ dsRed+ cells within the T cell zone was calculated for each condition. (E) The surface phenotype of transferred
WT and Ifnar1/ dsRed+ CD11c+ cells was assessed by flow cytometry.
Data information: Results are least squares mean  SEM (analyzed using a three-way full-factorial fit model, with contrast analysis used to test differences between
experimental groups). *P < 0.05, **P < 0.01, ****P < 0.0001. Data from one of three or more experiments (A, B) or three experiments pooled (C–E) (n = 3 wells per group
(A, B) or nine animals per group (C–E)).
ª 2017 The Authors The EMBO Journal
Lauren M Webb et al A role for IFN-I in Th2 induction by DCs The EMBO Journal
7
Published online: July 17, 2017 
on cDCs from mice treated with the IFNAR1-blocking antibody
MAR1-5A3 (Sheehan et al, 2006), indicating that expression of
these markers was IFN-I-driven (Fig 6D). Together, these data
demonstrate that SEA, S. mansoni eggs, and HDM stimulate an








Figure 6. IFN-I is required for Th2 induction in vivo.
A Splenic DCs were FACS-isolated following 12-h exposure to 50 lg SEA administered i.v. Cells were gated as intact singlets and cDCs identified as CD45R CD11c+
cells sorted to > 95% purity.
B mRNA expression of ISGs by splenic sorted cDCs was assessed by qPCR (normalized against Gapdh, a.u.) following in vivo exposure to SEA.
C mRNA expression of ISGs in whole lung following pulmonary challenge with Schistosoma mansoni eggs (normalized against beta-actin, a.u.).
D Mice were challenged i.d. with 100 lg HDM in conjunction with 200 lg of the IFNAR1-blocking Ab MAR1-5A3 or an isotype control. Twenty-four or 48 h later,
auricular LNs were harvested and CD317 and Sca-1 expression on cDCs analyzed.
E, F A total of 2,500 S. mansoni eggs were injected s.c. per foot into WT or Ifnar1/ mice, dLNs were harvested 7 days later, and cell counts were performed (E). (F) Cells
were cultured with anti-CD3 for 72 h and then cytokines measured by ELISA (medium background subtracted).
G IL-4eGFP mice were challenged i.d. with 100 lg HDM in conjunction with 200 lg of the IFNAR1-blocking Ab MAR1-5A3 or an isotype control. Mice were given a
second dose of Ab i.p. 48 h later. On day 7, dLNs were harvested and total cell numbers, CD44hi CD4+ T cell numbers, and IL-4eGFP+ T cell numbers assessed.
H A total of 2.5 × 103 S. mansoni eggs were injected s.c. with (+DC) or without 1 × 106 WT FLDCs into WT or Ifnar1/ recipients. On day 7, dLNs were harvested, cells
were stimulated with anti-CD3 for 72 h, and cytokines were measured by ELISA (medium background subtracted).
Data information: Results are mean  SEM (B–E, G) (one-way ANOVA) or least squares mean  SEM (F, H) (analyzed using a three-way full-factorial fit model, with
contrast analysis used to test differences between experimental groups). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Data from one of three or more
experiments (A–E, G) (n = 2–5 animals per group, five replicate wells), or data from three (H) or six (F) experiments pooled. a.u., arbitrary units.
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We next assessed the importance of IFN-I responsiveness for Th2
development after direct in vivo challenge with either dead
S. mansoni eggs or HDM. While WT mice displayed significantly
increased cellularity in the dLN following S. mansoni egg injection,
this was not evident in similarly challenged Ifnar1/ mice (Fig 6E).
Importantly, there was a significant defect in Th2 polarization and
IFNc induction in the dLN of Ifnar1/ mice after egg injection
(Fig 6F). This was not just a feature of helminth Th2 immunity, or
of Ifnar1/ mice, as administration of the IFNAR1-neutralizing
antibody MAR1-5A3 (Sheehan et al, 2006) significantly impaired
cellularity, and numbers of dLN CD44hi effector and IL-4-producing
CD4+ T cells, in the dLNs of mice sensitized i.d. with HDM
(Fig 6G). Finally, this impairment in Th2 induction in Ifnar1/
mice after egg injection was “rescued” by co-transfer of WT FLDCs
(Fig 6H), indicating that IFN-I responsiveness in DCs alone is suffi-
cient for Th2 initiation in an Ifnar1/ environment. Together, these
data establish the importance of IFNAR1 signaling in DCs for opti-
mal Th2 polarization against either helminths or allergens in vivo.
Discussion
We have identified IFN-I production by DCs responding to Th2 Ag
(Fig 1) and demonstrated for the first time that IFN-I responsiveness
is essential for optimal DC activation and effective Th2 response
induction in vivo (Figs 3 and EV4). This extends our fundamental
understanding of the context-dependent role for IFN-I during
immune response development, building upon previous studies in
which it has been implicated as an important regulator of basal DC
activation (Montoya, 2002), and function during viral infection
(Pinto et al, 2011).
A key aspect of DC activity controlled by IFN-I signaling, which
is essential for APC function, is effective migration (Kapsenberg,
2003; Alvarez et al, 2008). Studies using in vitro migration assays
have previously suggested that IFN-I is required for effective trans-
migration (Mattei et al, 2009; Rouzaut et al, 2010). Our study is the
first to demonstrate the importance of IFN-I in promoting DC migra-
tion in vivo—from the tissue site, via the lymphatics, to the dLN—in
response to pathogen-associated Ag (Fig 5).
Perhaps surprisingly, there is very little work currently published
that has focused on the migratory capacity of DCs in a Th2 setting.
While it is widely accepted that CCR7 and its ligands CCL19 and
CCL21 are the key chemokine receptor–ligand pairs that control DC
migration under most circumstances (Alvarez et al, 2008), León
et al (2012) suggested that during helminth infection, the essential
chemokine that governs DC Th2 induction is CXCR5 (León et al,
2012). CXCR5 interacts with CXCL13 and is required for the forma-
tion of germinal centers (Crotty, 2011). CCR7 was expressed to
some degree on cDCs cultured in medium alone (Fig 5), perhaps
accounting for the homeostatic migration of unstimulated DCs that
is evident in Fig 2. Although we identified SEA-specific upregulation
of CCR7 expression on cDCs, significant CXCR5 expression was not
seen under any circumstances (Fig 5). Further, our data demon-
strate an integral role for signaling via IFNAR1 in effective DC Th2
priming and LN T cell zone localization in vivo, strongly indicating
that DC induction of Th2 responses does not require localization to
the fringe of the B cell zone, as has previously been proposed (León
et al, 2012). It is possible that at later stages of immune activation
during helminth infection, CXCR5 becomes more important for T
cell polarization and for T follicular helper cell differentiation
(Fairfax et al, 2015), while in the early stages of Th2 induction
CCR7 plays a more dominant role. Further work is required to deter-
mine whether distinct chemokine receptor–ligand pairs are key for
DC function at different stages of type 2 differentiation.
As reported by others in non-Th2 settings (Mattei et al, 2009),
we found that CCR7 upregulation on SEA-activated cDCs was
controlled by IFNAR1 signaling, particularly on cDC2s (Fig 5), the
primary DC subset responsible for Th2 priming. Additionally, by
phenotypic analysis of DCs post-transfer, we identified that optimal
expression of the integrin LFA-1 also depended on IFNAR1 (Fig 5).
It has previously been shown using human PBMC DCs that LFA-1
facilitates transmigration of DCs across endothelium and is upregu-
lated on DCs by IFN-I treatment (Rouzaut et al, 2010). Further,
disruption of Rap1, which is required for cell surface stabilization of
LFA-1 (Hogg et al, 2011), leads to decreased GMDC ability to local-
ize to T cell zones of skin dLN (Katagiri et al, 2004). As it has been
shown that Rap1 activation is also controlled by IFNAR (Platanias,
2005), this adds further weight to our hypothesis that IFN-I may be
influencing cDC migration by facilitating the upregulation of impor-
tant chemokine receptors and integrins on the surface of cDCs.
Thus, it is likely that the combined impact of reduced CCR7 and
LFA-1 accounts for defective migration and homing of Ifnar1/
FLDCs in vivo. In addition, the significant reduction in cDC expres-
sion of MHC II, CD40, CD86, and PD-L2 (Fig 3C), all thought to be
involved in Th2 induction (MacDonald et al, 2001, 2002; Straw
et al, 2003; Gao et al, 2013), likely contributes to the striking inabil-
ity of Ifnar1/ FLDCs to effectively prime Th2 responses in vivo.
CD40 in particular has been shown to be essential for this process
(MacDonald et al, 2002), and the significant impairment in CD40
expression is likely to contribute to the phenotype we see in vivo.
In our work, despite lower levels of activation (Fig 3), Ifnar1/
cDC APC ability was not significantly impaired in vitro (Fig 4),
contrasting previously published reports that suggested a reduced
priming capacity of Ifnar1/ cDCs in OVA-specific T cell priming
models in vitro (Montoya, 2002; Diamond & Farzan, 2013). This
discrepancy could be due to technical differences, for example, Ag
availability or the ratio of DCs:T cells present, that might alter the
importance of cDC IFN-I responsiveness during T cell activation
in vitro. Conceivably, the strikingly impaired Th2 priming by
Ifnar1/ DCs that we have identified following their adoptive trans-
fer into recipient mice (Fig 3) may in part be due to restricted Ag
availability and a relatively small Ag-specific T cell pool in vivo in
WT mice.
An important aspect of DC function in type 2 settings that
remains poorly understood is the pattern recognition receptors
(PRRs) and pathways used by DCs to respond to Th2-associated Ag,
and how these might influence Th2 priming. Here, we demonstrate
that the FLDC IFN-I response to SEA is dependent on the adaptor
protein TRIF, while MyD88 acts as a negative regulator of this
pathway (Figs 1 and EV4). Identification of TRIF as an important
adaptor protein for DC activation by SEA suggests a role for the
TRIF-dependent PRRs in sensing IFN-I inducing ligands following
exposure to Th2 Ag (Fig EV4). Such PRRs are primarily nucleic acid
sensing and include TLR3, TLR4, and the cytoplasmic receptor
complex DDX1–DDX21–DDX36 (Broz & Monack, 2013; McNab et al,
2015). The role of MyD88 as a negative regulator of PRR signaling
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has not previously been reported in a Th2 setting, although it is
known that Th2 induction is not impaired in the absence of splenic
DC, GMDC, or global MyD88 expression (Layland et al, 2005;
Jankovic et al, 2002, 2004; Marshall & Pearce, 2008). Our data
demonstrate a requirement for TRIF in optimal FLDC activation in
response to a Th2 Ag and highlight the need for further study in this
area to address the impact of TRIF deficiency on DC Th2 induction.
Additionally, our demonstration of FLDC IFN-I induction by the key
immunostimulatory molecule in SEA omega-1 (Fig 1) suggests that
glycoproteins and C-type lectin receptors such as the mannose
receptor, which has been shown to recognize omega-1 (Everts et al,
2012), may be involved in this process.
Having identified that there was a degree of differential expres-
sion of the IFN-I subtypes IFNa3, IFNa6, and IFNb by cDCs respond-
ing to Th2 Ag (Fig 1), it would be of interest to characterize cDC
expression of additional IFN-I subtypes in response to different Th2
Ags. Whether distinct subtypes are more or less responsible for
conferring effective Th2 induction ability on cDCs remains to be
shown, although current understanding is that the diverse IFN-I
subtypes exert similar biological function in viral infection (van
Pesch et al, 2004).
The question of why IFN-I induction, normally associated with
intracellular infections, has evolved against a helminth parasite, and
whether this IFN-I signal benefits the host and/or the parasite,
remains. IFN-I has previously been suggested to act as a damage
signal that enhances early innate immune activation (Gregorio et al,
2010). Many of the PRRs that induce IFN-I production sense nucleic
acid ligands (McNab et al, 2015). Our work comparing the IFN-I
signature induced by live or dead eggs (Figs 1 and EV1) suggests that
the molecules responsible for IFN-I induction are primarily compo-
nents released by dead or dying eggs. This would include omega-1, as
well as implicating ligands such as nucleic acids that are not normally
secreted by live intact eggs. In addition, omega-1 is a RNase that
degrades messenger RNAs (Everts et al, 2012), likely leading to the
production of self-nucleic acid ligands. This RNase activity is essential
for the Th2-polarizing capacity of omega-1 (Everts et al, 2012). Thus,
it is possible that one way that Th2 Ag enhances polarization of Th2
cells may be via the stimulation of IFN-I production, a previously
unrecognized role for this damage-associated signal. It has also been
shown that IFN-I can limit IL-12 production upon secondary stimula-
tion with TLRs (McNab et al, 2015); thus, IFN-I may also promote
Th2 polarization by blocking differentiation down the Th1 route.
Our identification of this central role for IFN-I in DC Th2 promo-
tion raises many new questions about the broader impact of IFN-I
during type 2 inflammation. Importantly, the DC focus of our work
does not exclude additional roles for IFN-I in the wider Th2 setting,
and how IFN-I may influence effector functions of other immune
cells during helminth infection remains to be determined. Similarly,
our identification of a DC-derived source of IFN-I does not rule out
its production by additional cell types exposed to helminth products
or allergens in vivo (Fig EV4). Discovery of a key role for IFN-I in
DC Th2 ability has implications not only for development of thera-
peutics aimed at modulating type 2 responses, but also in the
context of helminth co-infection with bacterial or viral pathogens,
where IFN-I is known to impact dramatically on disease outcome
(McNab et al, 2015). In future work, it will be important to define
whether IFN-I induced in response to helminth Ag is a long-term
cost, or benefit, to pathogen and host.
Together, our work emphasizes the pleiotropic nature of IFN-I
and the importance of considering the previously unappreciated role
of this family of cytokines, ordinarily associated with antiviral
immunity, in promotion of type 2 inflammation.
Materials and Methods
Mice
C57BL/6xIL-4eGFP, dsRed, dsRedxIfnar1/, Ifnar1/, Myd88/,
IFNa6GFP, KN2xIL-4eGFP, KN2xIL-10eGFP, KN2xIL-13eGFP, OT-
IIxLy5.1, and Trif/ mice, all on the C57BL/6 background, were
bred and maintained at the University of Edinburgh, the University of
Manchester, or the Malaghan Institute of Medical Research, under
specific pathogen-free conditions (Hwang et al, 1995; Adachi et al,
1998; Barnden et al, 1998; Yamamoto, 2003; Vintersten et al, 2004;
Mohrs et al, 2005; Kamanaka et al, 2006; Kumagai et al, 2007; Neill
et al, 2010). Control C57BL/6 (WT) mice were either bred and main-
tained in-house or obtained commercially from Harlan or the Jackson
Laboratory. Experiments were conducted under a license granted by
the Home Office (UK), in accordance with local guidelines, or under
approval from the Victoria University Animal Ethics Committee, and
performed according to Malaghan Institute guidelines (HDM chal-
lenge in IL-4eGFP mice), or under approval from the ethics committee
of the University of Liege (S. mansoni egg lung challenge model).
Cell culture
For FLDC generation, BM cells were cultured with 200 ng/ml Flt3-L
(PeproTech), according to published methods (Naik et al, 2010).
Briefly, BM cells were flushed from femurs and tibia of adult mice and
resuspended for counting after red blood cell (RBC) lysis. Cells were
then cultured at 37°C 5% CO2 at 1.5 × 10
6 cells/ml in RPMI 1640
medium (Sigma) containing Flt3-L, 10% fetal calf serum (Sigma),
2 mM L-glutamine, 50 mM 2-mercaptoethanol (Invitrogen), 50 U/ml
penicillin, and 50 lg/ml streptomycin (Sigma). FLDCs were harvested
on d8 and replated at 2 × 106/ml for 18 h in the presence or absence
of Ag. For gene expression analyses, cells were cultured for 6 h in
medium alone or with Ag. Cells were exposed to 25 lg/ml SEA,
5 lg/ml St, 50 lg/ml HDM (Dermatophagoides pteronyssinus; Greer
Laboratories), 1:500 live S. mansoni eggs (purified from the livers of
C57BL/6 mice at approximately day 49 of S. mansoni infection), or
dead eggs (freeze/thawed) or 500 ng/ml recombinant omega-1 (gen-
erated in Nicotiana benthamiana and purified from the leaf extracellu-
lar space using POROS 50 cation resin (Life Technologies) (Wilbers
et al, 2017). Endotoxin-free SEA from S. mansoni eggs was prepared
in-house as previously described (MacDonald et al, 2001). In brief,
S. mansoni eggs were homogenized using a Tenbroeck tissue grinder
in PBS, and supernatant was collected, centrifuged, filtered
(0.45 lm), and stored at 70°C. St, strain SL3261, was provided by
Dr. Maurice Gallagher (University of Edinburgh) and was heat-killed
by incubation at 80°C for 30 min and stored in PBS at 4°C until use.
FLDC sorting and flow cytometry
For some experiments, FLDC bulk cultures were sorted by FACS
into separate subset populations prior to Ag stimulation. FLDCs
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were harvested on d8 of culture, and following FcR-Block (2.4G2),
cells were surface-stained with mAbs against CD11c, CD45R (B220),
CD11b, and CD24. Sorted or unsorted DC populations were replated
at 2 × 106/ml and stimulated with Ag for 18 h as described above.
Following Ag stimulation, DC surface activation was assessed by
flow cytometry. Cells were first stained with LIVE/DEAD Fixable
Aqua or UV (Life Technologies) and, following FcR-Block, were
stained with combinations of the following mAbs: CCR7, CD11b,
CD11c, CD24, CD40, CD45R, CD301b, CXCR5, CD86, MHC II, and
PD-L2. For analysis of cell viability, cells were stained with Annexin
V and 7-AAD. All antibodies for flow cytometry were purchased
from BD, eBioscience, or BioLegend. IFNa6GFP FLDCs were also
stained with the above antibodies and their expression of GFP
analyzed by flow cytometry. To assess antigen uptake, 2 × 105
FLDCs were incubated with 10 lg DQ-OVA (Life Technologies) for
2 h at 37°C or 4°C, before flow cytometric analysis. Samples were
acquired on a FACSCanto II or LSR-Fortessa flow cytometer using
BD FACSDiva Software and analyzed with FlowJo software (Tree
Star, Inc.) to ascertain proportional expression and geometric mean
fluorescence intensity (gMFI) for surface marker expression.
Cell tracking and transfer
For cell tracking and transfer experiments, WT, dsRed+, Ifnar1/,
or Ifnar1/ dsRed+ FLDCs were cultured as above for 6 or 18 h,
with SEA or St or in medium alone. For tracking of dsRed+ cells,
FLDCs were injected subcutaneously (s.c.) into WT recipients
(1 × 106/foot). Following dsRed+ cell transfer, dLNs were harvested
at 48 h post-injection. Popliteal LNs (pLNs) were digested at 37°C for
30 min with 0.4 U/ml Liberase TL (Roche) and 80 U/ml DNase I type
IV (Sigma). Single-cell suspensions were prepared by mechanical
disruption of LNs through a 70-lm filter. LN suspensions were then
analyzed by flow cytometry for the presence of dsRed+ CD11c+
cells. dLN cells were first stained with LIVE/DEAD Fixable Aqua or
UV, and following FcR-Block, cells were stained with mAb against
CD11b, CD11c, CD24, CD45R, CD86, CCR7, ICAM-1, and LFA-1. Iden-
tification of transferred cells was performed following exclusion of
Lin+ cells using CD3, CD19, CD49b, Ly6G, and NK1.1. Monocytes
(Ly6C+ CD11b+) and macrophages (CD11c F4/80+) were also
excluded. For cell transfer experiments, FLDCs were injected into WT
recipients (0.25 × 106/foot) and dLNs harvested 7 days later. Single-
cell suspensions of LN cells (5 × 106 cells/ml) were cultured in
X-VIVO 15 medium (Lonza) containing 2 mM L-glutamine and 50 lM
2-ME (Life Technologies) in 96-well plates at 37°C 5% CO2 and stimu-
lated with SEA (15 lg/ml) or St (1 lg/ml). Supernatants were
harvested after 72 h and cytokine production assessed by ELISA.
Immunohistochemistry
Following dsRed+ cell transfer, dLNs from recipient mice were fixed
in 4% paraformaldehyde (PFA; Sigma), incubated sequentially in 15
and 30% sucrose (Sigma) solutions overnight to quench residual
PFA, and then mounted in Optimal Cutting Temperature (O.C.T.)
embedding medium (Sakura). Thin-section confocal microscopy was
performed on 20-lm cryostat sections, which were fixed in ice-cold
acetone for 10 min, and then incubated for 1 h with mAb against
CD3 conjugated to 488 (eBioscience, UK), and CD45R conjugated to
Alexa647 (BD Biosciences, UK). Slides were washed extensively in
PBS–Tween-20, PBS, and then water before nuclei were stained with
DAPI-supplemented ProLong Fade Gold (Life Technologies) mount-
ing media. Samples were imaged at room temperature (~23°C) using
TCS SP5 II or TCS SP8 CW microscopes (Leica Microsystems), with
laser lines with emission wavelengths of 405 (DAPI), 488 (Alexa
Fluor 488), 543 (dsRed), and 633 and 647 (Alexa Fluor 647) nm, with
20× (HC PL APO; N.A. = 0.75), 40× (HCX PL APO CS; N.A. = 1.25),
and 63× (HCX PL APO; N.A. = 1.4) objectives with immersion oil
(Type F, Leica), using LAS AP or LAS X software (Leica). Fluorophore
emission light was collected using PMT or Hybrid Detectors (HyD).
Data were rendered and analyzed using Volocity (Improvision) or
ImageJ (NIH) software. To analyze the localization of dsRed+ cells in
specific dLN regions, the total LN area was measured on a binary
image of the DAPI staining, the B cell zone area identified using
CD45R staining, and the T cell zone as the CD45R region. A thresh-
old of 65-255 (the mean intensity of background in uninjected
samples) was applied to the dsRed channel and the total area of
dsRed ascertained. dsRed+ cells within the T cell zone were then
calculated as a percentage of all dsRed+ cells within the LN.
Immunizations and in vivo treatments
To assess the IFN-I signature of in vivo DCs responding to Th2 Ag,
mice were injected intravenously with PBS or 50 lg SEA. Eighteen
hours later, spleens were digested (as pLN, above) for 15 min at
37°C, single-cell suspensions prepared by mechanical disruption
through 70-lm filters and low-density cells enriched using NycoPrep
(1.077 g/ml; Axis-Shield). For purification of splenic DCs, non-DC
lineage cells were removed using biotinylated mAbs against murine
CD2, CD3e, CD49b, mIgM, and erythrocytes (Ter-119) and MyOne
Streptavidin Dynabeads (Invitrogen). Cells were then stained with
antibodies against CD11c and CD45R and cDCs sorted as
CD11chi CD45R directly into RNALater (Ambion) for subsequent
RNA extraction. To assess Th2 priming in vivo, 2.5 × 103 dead
S. mansoni eggs were injected s.c. per foot into recipient mice. In
some experiments, 1 × 106 WT FLDCs were co-transferred with
S. mansoni eggs. Draining pLNs were harvested 7 days later, and
restimulated with plate-bound aCD3 (0.5 lg/well) for 72 h. An
alternative model of in vivo priming involved intradermal (i.d.) chal-
lenge into the ear pinnae with 100 lg HDM whole bodies. Auricular
dLNs were collected 24 h, 48 h, or 7 days later. Flow cytometry was
used to analyze CD45R cDC expression of CD317 and Sca-1 at 24 h
or 48 h, and to assess the number of IL-4eGFP+ T cells at day 7. In
these experiments, mice were either treated with an anti-IFNAR1
antibody (MAR1-5A3) or an isotype control (MOPC-21; both from
BioXcell), with 200 lg Ab mixed with HDM given i.d. Mice received
a second Ab dose 48 h later i.p. In order to address induction of ISG
expression following dead S. mansoni egg challenge of the lung,
mice were injected with 5,000 dead S. mansoni eggs i.p. On day 14
mice were challenged with 5,000 dead eggs i.v. Lungs were then
collected on day 22 and a portion reserved for gene expression
analysis.
ELISA
ELISAs were performed on culture supernatants using paired mAb
and recombinant cytokine standards, or DuoSets (BioLegend, eBio-
science, BD, R&D Systems, and PeproTech). For restimulation data,
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medium-alone values were subtracted from Ag restimulated cyto-
kine levels for each sample.
RNA extraction and qPCR analysis
RNA was recovered from FLDCs or splenic DCs using TRIzol reagent
(Life Technologies) or RNALater, respectively. Lung tissue was
prepared using the mirVana miRNA isolation kit (Life Technologies).
RNA was translated into cDNA using Superscript III Reverse Tran-
scriptase and Oligo (dT; Life Technologies). Quantitative RT–PCR was
performed using a LightCycler 480 II Real-Time PCR machine (Roche)
and LightCycler-DNA master SYBR Green I (Roche) and compared to
a serially diluted standard of pooled cDNA. The relative amount of
mRNA for genes of interest was normalized to GAPDH or beta-actin.
The following primers were used: b-actin: 50-AGAGGGAAATCG
TGCGTGAC-30, 50-ACGGCCAGGTCATCACTATTG-30; Gapdh: 50-AAT
GTGTCCGTCGTGGATCT-30, 50-CCCAGCTCTCCCCATACATA-30; Ifit1:
50-TCTAAACAGGGCCTTGCAG-30, 50-GCAGAGCCCTTTTTGATAATG
T-30; Ifit3: 50-TGAACTGCTCAGCCCACA-30, 50-TCCCGGTTGACCTCAC
TC-30; Mx1: 50-TTCAAGGATCACTCATACTTCAGC-30, 50-GGGAGGTG
AGCTCCTCAGT-30; Oas1a: 50-GCTGCCAGCCTTTGATGT-30, 50-TGGC
ATAGATTGTGGGATCA-30; and Oasl2r: 50-GGATGCCTGGGAGAGAA
TCG-30, 50-CAGTTTCGAAGAGCAGGCGA-30.
DC: T cell co-culture assays
For CFSE dilution assays, splenic and LN CD4+ OT-II T cells were
purified using CD4+ Dynabeads (Life Technologies) following the
manufacturer’s protocol. T cells were labeled with 5 lM CFSE (Life
Technologies) for 15 min at 37°C, prior to culture with 5 × 104 WT
or Ifnar1/ FLDCs in the presence of 0.01 lg/ml OVA323–339
peptide (CRB) or 5 lg/ml OVA protein (Sigma) which had been
endotoxin depleted in-house. Cultures were incubated at 37°C for
4 days prior to assessment of CFSE dilution by flow cytometry. In
vitro co-culture polarization experiments were performed with
5 × 104 KN2xIL-13eGFP CD4+ or KN2xIL-10eGFP CD4+ T cells
which were cultured in 96-well plates for 4 days with 2,500 WT or
Ifnar1/ FLDCs, 1 lg/ml soluble anti-CD3, and with or without
rIL-4 (20 ng/ml; PeproTech; Cook et al, 2015). T cell expression of
huCD2 (IL-4; Life Technologies) or eGFP (IL-10 or IL-13) was then
assessed by flow cytometry.
Statistical analysis
Statistical analyses were carried out using GraphPad Prism 5 or JMP
(SAS Institute). The data were checked to confirm normality and
that groups had equal variance. One-way analysis of variance
(ANOVA) with Tukey’s multiple comparison tests was employed to
determine significant differences between sample groups. Results
from these tests were reported as significant if P ≤ 0.05, with results
from these tests shown as mean  SEM. For some experiments,
statistical analysis was carried out using JMP, in which case data
were analyzed using three-way full-factorial fit models to assess
effects such as “genotype”, “treatment”, and “experiment” on the
response variable of interest. This allowed the interaction between
effects to be taken into account in addition to their impact on the
response variable, which enabled experimental repeats to be pooled,
increasing the power of the analysis. The least squares mean results
table from the three-way full-factorial analysis was used to test the
contrast between specific experimental groups using a joint F-test. A
difference between experimental groups was taken to be significant
if the P-value (Prob > F) was less than or equal to 0.05, with results
in graphs shown as least squares mean  SEM.
Expanded View for this article is available online.
Acknowledgements
This work was supported by the MRC (G0701437 to A.S.M.) and the Wellcome
Trust (WT086628MA). R.J.L. is the recipient of a National Health and Medical
Research Council of Australia (NHMRC) Early Career Fellowship. Funding was
also provided to F.R. by the Health Research Council of New Zealand. B.G.D. is
a senior researcher from the F.R.S-FNRS. A.M.D. was funded by the ULg-Marie
Curie COFUND Program. C.J. is supported by the MRC (G0800311). The authors
thank John Grainger, James Hewitson, and Mark Travis for critical reading of
the manuscript, Rinku Rajan for technical support, Richard Preziosi for statisti-
cal advice, Martin Waterfall and Gareth Howell for cell sorting and assistance
with flow cytometry, and David Gray, Caetano Reis e Sousa, Andrew McKenzie,
Markus Mohrs, and Shizuo Akira for provision of OT-II × Ly5.1, Myd88/,
Trif/, IL-10eGFP, Ifnar1/, IL-13eGFP, KN2, and IFNa6GFP mice. Biom-
phalaria glabrata snails used to generate eggs and SEA for this research were
supplied by the N.I.A.I.D. Schistosomiasis Resource Center at the Biomedical
Research Institute (Rockville, MD), through Contract HHSN272201000005I for
distribution through BEI Resources, with the help of Mark Wilson.
Author contributions
LMW and RJL designed the project and coordinated and carried out the experi-
mental work. JGB and ANRC helped design the project and carried out the
microscopy work. SLB, AMD, LMC, LHJ-J, PCC, and ATP-A carried out the experi-
mental work. PCC, LHJ-J, and ATP-A contributed to the design of in vitro and
in vivo assays. RHPW contributed recombinant omega-1. DMD provided some
equipment and supervised some of the research. CJ provided IFNa6GFP mice.
BGD and FR supervised some of the research. ASM conceived and designed the
project and supervised the research. LMW, RJL, and ASM wrote the manuscript,
with valuable input from all the other authors.
Conflict of interest
F.R., A.S.M., and L.M.C. are listed as inventors on a provisional patent applica-
tion concerned with the subject matter of this paper. The MCCIR is a joint
venture between the University of Manchester, GSK, and AstraZeneca.
References
Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M,
Nakanishi K, Akira S (1998) Targeted disruption of the MyD88 gene results
in loss of IL-1- and IL-18-mediated function. Immunity 9: 143 – 150
Alvarez D, Vollmann EH, von Andrian UH (2008) Mechanisms and
consequences of dendritic cell migration. Immunity 29: 325 – 342
Barnden MJ, Allison J, Heath WR, Carbone FR (1998) Defective TCR expression
in transgenic mice constructed using cDNA-based a-and b-chain genes
under the control of heterologous regulatory elements. Immunol Cell Biol
76: 34 – 40
Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M (2006)
Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-
producing cells in the naive mouse, but a promiscuous cell surface
antigen following IFN stimulation. J Immunol 177: 3260 – 3265
The EMBO Journal ª 2017 The Authors
The EMBO Journal A role for IFN-I in Th2 induction by DCs Lauren M Webb et al
12
Published online: July 17, 2017 
Bouchery T, Kyle R, Ronchese F, Le Gros G (2014) The differentiation of CD4
(+) T-helper cell subsets in the context of helminth parasite infection.
Front Immunol 5: 487
Brasel K, De Smedt T, Smith JL, Maliszewski CR (2000) Generation of murine
dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood
96: 3029 – 3039
Braun A, Worbs T, Moschovakis GL, Halle S, Hoffmann K, Bölter J, Münk A,
Förster R (2011) Afferent lymph-derived T cells and DCs use different
chemokine receptor CCR7-dependent routes for entry into the lymph node
and intranodal migration. Nat Immunol 12: 879 – 887
Broz P, Monack DM (2013) Newly described pattern recognition
receptors team up against intracellular pathogens. Nat Rev Immunol 13:
551 – 565
Cass CL, Johnson JR, Califf LL, Xu T, Hernandez HJ, Stadecker MJ, Yates JR,
Williams DL (2007) Proteomic analysis of Schistosoma mansoni egg
secretions. Mol Biochem Parasitol 155: 84 – 93
Cook PC, Owen H, Deaton AM, Borger JG, Brown SL, Clouaire T, Jones G-R, Jones
LH, Lundie RJ, Marley AK, Morrison VL, Phythian-Adams AT, Wachter E, Webb
LM, Sutherland TE, Thomas GD, Grainger JR, Selfridge J, McKenzie ANJ, Allen
JE et al (2015) A dominant role for the methyl-CpG-binding protein Mbd2 in
controlling Th2 induction by dendritic cells. Nat Commun 6: 6920
Crotty S (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:
621 – 663
Diacovo TG (2005) Adhesive mechanisms governing interferon-producing cell
recruitment into lymph nodes. J Exp Med 202: 687 – 696
Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault
JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD
(2011) Type I interferon is selectively required by dendritic cells for
immune rejection of tumors. J Exp Med 208: 1989 – 2003
Diamond MS, Farzan M (2013) The broad-spectrum antiviral functions of IFIT
and IFITM proteins. Nat Rev Immunol 13: 46 – 57
Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, Haswell LE, Al-
Shamkhani A, Flavell R, Borrow P, Reis e Sousa C (2003) Viral infection
switches non-plasmacytoid dendritic cells into high interferon producers.
Nature 424: 324 – 328
Essers MAG, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA,
Trumpp A (2009) IFNa activates dormant haematopoietic stem cells
in vivo. Nature 458: 904 – 908
Everts B, Perona-Wright G, Smits HH, Hokke CH, van der Ham AJ,
Fitzsimmons CM, Doenhoff MJ, van der Bosch J, Mohrs K, Haas H, Mohrs
M, Yazdanbakhsh M, Schramm G (2009) Omega-1, a glycoprotein secreted
by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med 206:
1673 – 1680
Everts B, Hussaarts L, Driessen NN, Meevissen MHJ, Schramm G, van der
Ham AJ, van der Hoeven B, Scholzen T, Burgdorf S, Mohrs M, Pearce EJ,
Hokke CH, Haas H, Smits HH, Yazdanbakhsh M (2012) Schistosome-
derived omega-1 drives Th2 polarization by suppressing protein synthesis
following internalization by the mannose receptor. J Exp Med 209:
1753 – 1767
Everts B, Tussiwand R, Dreesen L, Fairfax KC, Huang SC-C, Smith AM,
O’Neill CM, Lam WY, Edelson BT, Urban JF, Murphy KM, Pearce EJ
(2016) Migratory CD103+ dendritic cells suppress helminth-driven type
2 immunity through constitutive expression of IL-12. J Exp Med 213:
35 – 51
Fairfax KC, Everts B, Amiel E, Smith AM, Schramm G, Haas H, Randolph GJ,
Taylor JJ, Pearce EJ (2015) IL-4-secreting secondary T follicular helper (Tfh)
cells arise from memory T cells, not persisting Tfh cells, through a B cell-
dependent mechanism. J Immunol 199: 2999 – 3010
Gao Y, Nish SA, Jiang R, Hou L, Licona-Limón P, Weinstein JS, Zhao H,
Medzhitov R (2013) Control of T helper 2 responses by transcription factor
IRF4-dependent dendritic cells. Immunity 39: 722 – 732
Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu X-L, Trinchieri G,
O’Garra A, Liu Y-J (2002) The development of murine plasmacytoid
dendritic cell precursors is differentially regulated by FLT3-ligand and
granulocyte/macrophage colony-stimulating factor. J Exp Med 195:
953 – 958
Gregorio J, Meller S, Conrad C, Di Nardo A, Homey B, Lauerma A, Arai N, Gallo
RL, Digiovanni J, Gilliet M (2010) Plasmacytoid dendritic cells sense skin
injury and promote wound healing through type I interferons. J Exp Med
207: 2921 – 2930
Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, Segura
E, Tussiwand R, Yona S (2014) Dendritic cells, monocytes and
macrophages: a unified nomenclature based on ontogeny. Nat Rev
Immunol 14: 571 – 578
Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MAM, Kool M,
Muskens F, Lambrecht BN (2010) Inflammatory dendritic cells–not
basophils–are necessary and sufficient for induction of Th2 immunity to
inhaled house dust mite allergen. J Exp Med 207: 2097 – 2111
Helft J, Böttcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, Goubau
D, Sousa CRE (2015) GM-CSF mouse bone marrow cultures comprise a
heterogeneous population of CD11c+MHC II+ macrophages and dendritic
cells. Immunity 42: 1197 – 1211
Hoffmann H-H, Schneider WM, Rice CM (2015) Interferons and viruses: an
evolutionary arms race of molecular interactions. Trends Immunol 36:
124 – 138
Hogg N, Patzak I, Willenbrock F (2011) The insider’s guide to leukocyte
integrin signalling and function. Nat Rev Immunol 11: 416 – 426
Hwang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, Hamilton JA,
Whitty G, Bertoncello I, Kola I (1995) A null mutation in the gene encoding
a type I interferon receptor component eliminates antiproliferative and
antiviral responses to interferons alpha and beta and alters macrophage
responses. Proc Natl Acad Sci USA 92: 11284 – 11288
Ivashkiv LB, Donlin LT (2014) Regulation of type I interferon responses. Nat
Rev Immunol 14: 36 – 49
Jankovic D, Kullberg MC, Hieny S, Caspar P, Collazo CM, Sher A (2002) In the
absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to
default to a Th2 pattern and are host protective in an IL-10(/) setting.
Immunity 16: 429 – 439
Jankovic D, Kullberg MC, Caspar P, Sher A (2004) Parasite-induced Th2
polarization is associated with down-regulated dendritic cell
responsiveness to Th1 stimuli and a transient delay in T lymphocyte
cycling. J Immunol 173: 2419 – 2427
Johnson AC, Li X, Pearlman E (2008) MyD88 functions as a negative regulator
of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-
Jun N-terminal kinase. J Biol Chem 283: 3988 – 3996
de Jong EC, Vieira PL, Kalinski P, Schuitemaker JHN, Tanaka Y, Wierenga
EA, Yazdanbakhsh M, Kapsenberg ML (2002) Microbial compounds
selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic
cells in vitro with diverse th cell-polarizing signals. J Immunol 168:
1704 – 1709
Kamanaka M, Kim ST, Wan YY, Sutterwala FS, Lara-Tejero M, Galán JE, Harhaj
E, Flavell RA (2006) Expression of interleukin-10 in intestinal lymphocytes
detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25:
941 – 952
Kapsenberg M (2003) Dendritic-cell control of pathogen-driven T-cell
polarization. Nat Rev Immunol 3: 984 – 993
ª 2017 The Authors The EMBO Journal
Lauren M Webb et al A role for IFN-I in Th2 induction by DCs The EMBO Journal
13
Published online: July 17, 2017 
Katagiri K, Ohnishi N, Kabashima K, Iyoda T, Takeda N, Shinkai Y, Inaba
K, Kinashi T (2004) Crucial functions of the Rap1 effector molecule
RAPL in lymphocyte and dendritic cell trafficking. Nat Immunol 5:
1045 – 1051
Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K,
Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S (2005) Cell type-
specific involvement of RIG-I in antiviral response. Immunity 23:
19 – 28
Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E, Aozasa K,
Kawai T, Akira S (2007) Alveolar macrophages are the primary
interferon-a producer in pulmonary infection with RNA viruses. Immunity
27: 240 – 252
Kumamoto Y, Linehan M, Weinstein JS, Laidlaw BJ, Craft JE, Iwasaki A (2013)
CD301b+ dermal dendritic cells drive T helper 2 cell-mediated immunity.
Immunity 39: 733 – 743
Larkin BM, Smith PM, Ponichtera HE, Shainheit MG, Rutitzky LI, Stadecker MJ
(2012) Induction and regulation of pathogenic Th17 cell responses in
schistosomiasis. Semin Immunopathol 34: 873 – 888
Layland LE, Wagner H, Da Costa CUP (2005) Lack of antigen-specific Th1
response alters granuloma formation and composition in Schistosoma
mansoni-infected MyD88/ mice. Eur J Immunol 35: 3248 – 3257
León B, Ballesteros-Tato A, Browning JL, Dunn R, Randall TD, Lund FE (2012)
Regulation of TH2 development by CXCR5+ dendritic cells and
lymphotoxin-expressing B cells. Nat Immunol 13: 681 – 690
Lundie RJ, Webb LM, Marley AK, Phythian-Adams AT, Cook PC, Jackson-
Jones LH, Brown S, Maizels RM, Boon L, O’Keeffe M, MacDonald AS
(2016) A central role for hepatic conventional dendritic cells in
supporting Th2 responses during helminth infection. Immunol Cell Biol
94: 400 – 410
MacDonald AS, Straw AD, Bauman B, Pearce EJ (2001) CD8- dendritic cell
activation status plays an integral role in influencing Th2 response
development. J Immunol 167: 1982 – 1988
MacDonald AS, Straw AD, Dalton NM, Pearce EJ (2002) Cutting edge: Th2
response induction by dendritic cells: a role for CD40. J Immunol 168:
537 – 540
MacDonald AS, Maizels RM (2008) Alarming dendritic cells for Th2 induction.
J Exp Med 205: 13 – 17
Marié I, Durbin JE, Levy DE (1998) Differential viral induction of distinct
interferon-alpha genes by positive feedback through interferon regulatory
factor-7. EMBO J 17: 6660 – 6669
Marshall F, Pearce E (2008) Uncoupling of induced protein processing from
maturation in dendritic cells exposed to a highly antigenic preparation
from a helminth parasite. J Immunol 181: 7562
Mattei F, Bracci L, Tough DF, Belardelli F, Schiavoni G (2009) Type I IFN
regulate DC turnover in vivo. Eur J Immunol 39: 1807 – 1818
McKenzie ANJ, Spits H, Eberl G (2014) Innate lymphoid cells in inflammation
and immunity. Immunity 41: 366 – 374
McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A (2015) Type I interferons
in infectious disease. Nat Rev Immunol 15: 87 – 103
Miyake T, Kumagai Y, Kato H, Guo Z, Matsushita K, Satoh T, Kawagoe T,
Kumar H, Jang MH, Kawai T, Tani T, Takeuchi O, Akira S (2009) Poly I: C-
induced activation of NK cells by CD8+ dendritic cells via the IPS-1 and
TRIF-dependent pathways. J Immunol 183: 2522 – 2528
Mohrs K, Wakil AE, Killeen N, Locksley RM, Mohrs M (2005) A two-step
process for cytokine production revealed by IL-4 dual-reporter mice.
Immunity 23: 419 –429
Montoya M (2002) Type I interferons produced by dendritic cells promote
their phenotypic and functional activation. Blood 99: 3263 – 3271
Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, Lahoud
MH, O’Keeffe M, Shao Q-X, Chen W-F, Villadangos JA, Shortman K, Wu L
(2005) Cutting edge: generation of splenic CD8+ and CD8 dendritic cell
equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J
Immunol 174: 6592 – 6597
Naik SH, O’Keeffe M, Proietto A, Shortman HHK, Wu L (2010) CD8+, CD8,
and plasmacytoid dendritic cell generation in vitro using flt3 ligand.
Methods Mol Biol 595: 167 – 176
Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA, Bucks C, Kane
CM, Fallon PG, Pannell R, Jolin HE, McKenzie ANJ (2010) Nuocytes
represent a new innate effector leukocyte that mediates type-2 immunity.
Nature 464: 1367 – 1370
Parlato S, Santini SM, Lapenta C, Di Pucchio T, Logozzi M, Spada M,
Giammarioli AM, Malorni W, Fais S, Belardelli F (2001) Expression of
CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced
monocyte-derived dendritic cells: importance for the rapid
acquisition of potent migratory and functional activities. Blood 98:
3022 – 3029
Pearce EJ, MacDonald AS (2002) The immunobiology of schistosomiasis. Nat
Rev Immunol 2: 499 – 511
Perona-Wright G, Lundie RJ, Jenkins SJ, Webb LM, Grencis RK, MacDonald AS
(2012) Concurrent bacterial stimulation alters the function of helminth-
activated dendritic cells, resulting in IL-17 induction. J Immunol 188:
2350 – 2358
van Pesch V, Lanaya H, Renauld J-C, Michiels T (2004) Characterization of the
murine alpha interferon gene family. J Virol 78: 8219 – 8228
Phythian-Adams AT, Cook PC, Lundie RJ, Jones LH, Smith KA, Barr TA,
Hochweller K, Anderton SM, Hammerling GJ, Maizels RM, MacDonald AS
(2010) CD11c depletion severely disrupts Th2 induction and development
in vivo. J Exp Med 207: 2089 – 2096
Pinto AK, Daffis S, Brien JD, Gainey MD, Yokoyama WM, Sheehan KCF,
Murphy KM, Schreiber RD, Diamond MS (2011) A temporal role of type I
interferon signaling in CD8+ T cell maturation during acute West Nile
virus infection. PLoS Pathog 7: e1002407
Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated
signalling. Nat Rev Immunol 5: 375 – 386
Rouzaut A, Garasa S, Teijeira Á, González I, Martinez-Forero I, Suarez N,
Larrea E, Alfaro C, Palazón A, Dubrot J, Hervás-Stubbs S, Melero I
(2010) Dendritic cells adhere to and transmigrate across lymphatic
endothelium in response to IFN-a. Eur J Immunol 40: 3054 – 3063
Sheehan KCF, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-
Arthur C, Carrero JA, White JM, Hertzog PJ, Schreiber RD (2006) Blocking
monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit
1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J
Interferon Cytokine Res 26: 804 – 819
Straw AD, MacDonald AS, Denkers EY, Pearce EJ (2003) CD154 plays a central
role in regulating dendritic cell activation during infections that induce
Th1 or Th2 responses. J Immunol 170: 727 – 734
Swiecki M, Colonna M (2010) Unraveling the functions of plasmacytoid
dendritic cells during viral infections, autoimmunity, and tolerance.
Immunol Rev 234: 142 – 162
Trottein F, Pavelka N, Vizzardelli C, Angeli V, Zouain CS, Pelizzola M,
Capozzoli M, Urbano M, Capron M, Belardelli F, Granucci F, Ricciardi-
Castagnoli P (2004) A type I IFN-dependent pathway induced by
Schistosoma mansoni eggs in mouse myeloid dendritic cells generates an
inflammatory signature. J Immunol 172: 3011 – 3017
Tussiwand R, Everts B, Grajales-Reyes GE, Kretzer NM, Iwata A, Bagaitkar J,
Wu X, Wong R, Anderson DA, Murphy TL, Pearce EJ, Murphy KM (2015)
The EMBO Journal ª 2017 The Authors
The EMBO Journal A role for IFN-I in Th2 induction by DCs Lauren M Webb et al
14
Published online: July 17, 2017 
Klf4 expression in conventional dendritic cells is required for T helper 2
cell responses. Immunity 42: 916 – 928
Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A
(2004) Mouse in red: Red fluorescent protein expression in mouse ES cells,
embryos, and adult animals. Genesis 40: 241 – 246
Wilbers RHP, Westerhof LB, van Noort K, Obieglo K, Driessen NN, Everts B,
Gringhuis SI, Schramm G, Goverse A, Smant G, Bakker J, Smits HH,
Yazdanbakhsh M, Schots A, Hokke CH (2017) Production and glyco-
engineering of immunomodulatory helminth glycoproteins in plants. Sci
Rep 7: 45910
Williams JW, Tjota MY, Clay BS, Vander Lugt B, Bandukwala HS, Hrusch CL,
Decker DC, Blaine KM, Fixsen BR, Singh H, Sciammas R, Sperling AI (2013)
Transcription factor IRF4 drives dendritic cells to promote Th2
differentiation. Nat Commun 4: 2990
Wynn TA, Morawetz R, Scharton-Kersten T, Hieny S, Morse HC,
Kühn R, Müller W, Cheever AW, Sher A (1997) Analysis of
granuloma formation in double cytokine-deficient mice reveals
a central role for IL-10 in polarizing both T helper cell 1- and
T helper cell 2-type cytokine responses in vivo. J Immunol 159:
5014 – 5023
Yamamoto M (2003) Role of adaptor TRIF in the MyD88-independent toll-like
receptor signaling pathway. Science 301: 640 – 643
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
ª 2017 The Authors The EMBO Journal
Lauren M Webb et al A role for IFN-I in Th2 induction by DCs The EMBO Journal
15
Published online: July 17, 2017 
